With over 1.57 million Titan Medical Inc. (TMDI) shares trading Thursday and a closing price of $0.91 on the day, the dollar volume was approximately $1.43 million. The shares have shown a positive weekly performance of 3.64% and its price on 07/30/20 lost nearly -0.73%. Currently, there are 73.83M common shares owned by the public and among those 59.84M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for TMDI have a consensus price objective of $1.00. The analysts have set the share’s price value over the next 12 months at a high of $1.00 and a low of $1.00 should the stock experience a downside. But an upside of 9.0% will see the stock hit the forecast high price target while mean target price for the stock is $1.00.
Perritt Ultra Micro Cap Fund owns 0.0 shares of the company’s stock, all valued at over $0.0. The company sold -0.2 million shares recently to bring their total holdings to about 0.00% of the shares outstanding.
Shares of Titan Medical Inc. (NASDAQ: TMDI) opened at $0.947, up $0.03 from a prior closing price of $0.92. However, the script later closed the day at $0.91, down -0.73%. The company’s stock has a 5-day price change of 3.64% and 206.40% over the past three months. TMDI shares are trading 83.84% year to date (YTD), with the 12-month market performance down to -54.50% lower. It has a 12-month low price of $0.12 and touched a high of $2.71 over the same period. Currently, 1.57 million shares have been traded, compared to an average intraday trading volume of 4.40 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.61%, 11.17%, and 75.16% respectively.
Institutional ownership of Titan Medical Inc. (NASDAQ: TMDI) shares accounts for 3.55% of the company’s 73.83M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $67.19M. The earnings-per-share (ttm) stands at -$0.40. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.93% over the week and 10.43% over the month.
Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 1 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the TMDI, a number of firms have released research notes about the stock. Piper Jaffray stated their Overweight rating for the stock in a research note on May 22, 2019, with the firm’s price target at $6.